Filing Details

Accession Number:
0001562180-24-007124
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-02 16:06:16
Reporting Period:
2024-09-30
Accepted Time:
2024-10-02 16:06:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293971 Bluebird Bio Inc. BLUE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1839697 Andrew Obenshain C/O Bluebird Bio, Inc.
455 Grand Union Boulevard
Somerville MA 02145
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-30 130,000 $0.00 409,998 No 4 A Direct
Common Stock Disposition 2024-09-30 34,780 $0.53 375,218 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. These restricted stock units for common stock vest over a four-year period at the rate of 25% on each of March 1, 2025, March 1, 2026, March 1, 2027 and March 1, 2028. These restricted stock units were approved during the Issuer's regular annual review cycle for 2024 with a delayed date of issuance.
  2. Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  3. The range in prices for the transaction reported on this line was $0.5211 to $0.5273. The average weighted price was $0.5253. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.